Opinion on Therapy Area

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

DuPont / Kos Pharmaceuticals: a good combination for dyslipidemia

Published By Datamonitor
28 Sep 2000
CommentWire
CommentWire

Pfizer strikes in the battle for the US Alzheimer's market

Published By Datamonitor
28 Sep 2000
Expert View
Expert View

Making the most of new indications

Published By Datamonitor
29 Sep 2000
CommentWire
CommentWire

Vitamin C: benefits of supplements still in question

Published By Datamonitor
05 Oct 2000
CommentWire
CommentWire

UCB: winning European market with novel anti-epileptic?

Published By Datamonitor
05 Oct 2000
CommentWire
CommentWire

AVAX: cell banking heralds new era in cancer care

Published By Datamonitor
09 Oct 2000
CommentWire
CommentWire

Anti-platelets: NICE ruling for Merck and Co

Published By Datamonitor
11 Oct 2000
CommentWire
CommentWire

Cephalon/Anesta: painful times could be ahead

Published By Datamonitor
12 Oct 2000
Expert View
Expert View

Inoculating the cancer market

Published By Datamonitor
13 Oct 2000
CommentWire
CommentWire

Pfizer: more pressure on inhaled insulins

Published By Datamonitor
16 Oct 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.